Apollo Hospitals Enterprise Ltd. is Rated Hold

3 hours ago
share
Share Via
Apollo Hospitals Enterprise Ltd. is rated 'Hold' by MarketsMojo, with this rating last updated on 09 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.
Apollo Hospitals Enterprise Ltd. is Rated Hold

Current Rating and Its Significance

The 'Hold' rating assigned to Apollo Hospitals Enterprise Ltd. indicates a balanced outlook for investors. It suggests that while the stock remains a viable investment, it may not offer the same upside potential as stocks rated 'Buy' or 'Strong Buy'. This rating encourages investors to maintain their existing positions rather than aggressively accumulate or divest shares. The assessment is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Quality Assessment

As of 03 February 2026, Apollo Hospitals demonstrates a strong quality profile. The company holds a 'good' quality grade, reflecting robust operational efficiency and management effectiveness. A notable highlight is its high Return on Capital Employed (ROCE) of 16.84%, signalling efficient utilisation of capital to generate profits. Additionally, the company has maintained positive results for eight consecutive quarters, underscoring consistent operational performance. The quarterly operating profit to interest ratio stands at an impressive 8.59 times, indicating a comfortable buffer to service debt obligations.

Valuation Perspective

The valuation grade for Apollo Hospitals is classified as 'attractive'. The stock trades at an Enterprise Value to Capital Employed ratio of 7.5, which is below the average historical valuations of its peers, suggesting it is reasonably priced relative to its capital base. Furthermore, the company’s PEG ratio of 1.4 indicates that its price is fairly aligned with its earnings growth prospects. Over the past year, the stock has delivered a return of 4.22%, while profits have surged by 41.3%, reflecting a healthy growth trajectory that supports its current valuation.

Financial Trend and Stability

Financially, Apollo Hospitals is in a positive trend. Net sales have grown at an annualised rate of 16.66%, with operating profit expanding even more rapidly at 37.14%. The company’s debt position remains manageable, with a Debt to EBITDA ratio of 1.48 times, highlighting strong debt servicing capability. Institutional investors hold a significant 65.27% stake, which often correlates with confidence in the company’s fundamentals and governance. This strong backing by knowledgeable investors adds a layer of stability to the stock’s outlook.

Technical Analysis

From a technical standpoint, the stock currently exhibits a 'bearish' grade. Despite short-term price fluctuations, including a 1.93% gain on the latest trading day and a 4.01% rise over the past week, the stock has experienced declines over the last three months (-9.68%) and six months (-3.76%). Year-to-date, the stock has marginally increased by 0.35%. These mixed signals suggest some caution for traders relying on technical momentum, reinforcing the 'Hold' stance for investors who prefer a more measured approach.

Performance Overview

As of 03 February 2026, Apollo Hospitals Enterprise Ltd. is classified as a large-cap stock within the hospital sector. The company’s market capitalisation reflects its established position in the healthcare industry. The stock’s performance over various time frames shows resilience amid market volatility, with a one-year return of 4.22% and a modest year-to-date gain. These figures, combined with strong fundamentals, support the current rating and provide a nuanced picture for investors weighing their options.

Summary for Investors

Investors considering Apollo Hospitals should view the 'Hold' rating as an indication to maintain their current holdings while monitoring market and company developments closely. The company’s strong quality and financial metrics provide a solid foundation, while the attractive valuation offers some cushion against downside risks. However, the bearish technical signals and recent price volatility suggest that new investors might wait for clearer momentum before entering. Overall, the rating reflects a balanced risk-reward profile suitable for investors with a moderate risk appetite.

Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!

  • - Rigorous evaluation cleared
  • - Expert-backed selection
  • - Mid Cap conviction pick

See Expert Backing →

Contextualising the Rating

The 'Hold' rating for Apollo Hospitals Enterprise Ltd. is a reflection of its current standing in a dynamic healthcare sector. While the company continues to demonstrate strong operational metrics and a healthy financial trend, the valuation and technical indicators suggest a cautious approach. This rating serves as a guide for investors to balance their portfolios, recognising the company’s strengths while being mindful of market fluctuations and sector-specific challenges.

Looking Ahead

Going forward, investors should watch for developments in Apollo Hospitals’ quarterly results, sectoral trends, and broader market conditions. Continued growth in net sales and operating profit, alongside stable debt metrics, will be key drivers for potential rating reassessments. Additionally, shifts in technical momentum could influence short-term trading opportunities. For now, the 'Hold' rating encapsulates a prudent stance, encouraging investors to stay informed and consider the stock’s fundamentals alongside market signals.

Conclusion

In summary, Apollo Hospitals Enterprise Ltd. is rated 'Hold' by MarketsMOJO as of 09 January 2026, with all financial and market data reflecting the position as of 03 February 2026. The company’s strong quality and financial trend, combined with an attractive valuation, are tempered by bearish technical indicators. This balanced view provides investors with a comprehensive understanding of the stock’s current outlook, supporting informed decision-making in a complex market environment.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News